Clinical Trial Update: Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major Depression [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating photobiomodulation to modify cerebral blood flow and emotional status in patients with major depressive disorder has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Post-traumatic Stress Disorder
• Substance Use Disorder

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depression, Anxiety Disorder | Phase 1 | Status: COMPLETED